These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19575225)

  • 1. Efficacy of a single topical application of Advantage Multi (= Advocate) Topical Solution (10% imidocloprid + 2.5% moxidectin) in the treatment of dogs experimentally infected with Crenosoma vulpis.
    Conboy G; Hare J; Charles S; Settje T; Heine J
    Parasitol Res; 2009 Aug; 105 Suppl 1():S49-54. PubMed ID: 19575225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Milbemax (milbemycin oxime + praziquantel) in the treatment of dogs experimentally infected with Crenosoma vulpis.
    Conboy G; Bourque A; Miller L; Seewald W; Schenker R
    Vet Parasitol; 2013 Dec; 198(3-4):319-24. PubMed ID: 24144516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imidacloprid plus moxidectin topical solution for the prevention of heartworm disease (Dirofiloria immitis) in dogs.
    Arther RG; Bowman DD; Slone RL; Travis LE
    Parasitol Res; 2005 Oct; 97 Suppl 1():S76-S80. PubMed ID: 16228279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental infection with Ancylostoma ceylanicum in dogs and efficacy of a spot on combination containing imidacloprid 10% and moxidectin 2.5% (Advocate/Advantage Multi, Bayer Animal Health).
    Taweethavonsawat P; Chungpivat S; Satranarakun P; Traub RJ; Schaper R
    Parasitol Res; 2010 May; 106(6):1499-502. PubMed ID: 20349196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory Evaluation of the Efficacy of 10 % Imidacloprid + 2.5 % Moxidectin Topical Solution (Advantage® Multi, Advocate®) for the Treatment of Dirofilaria immitis Circulating Microfilariae in Dogs.
    Bowman DD; Charles SD; Arther RG; Settje T
    Parasitol Res; 2015 Aug; 114 Suppl 1():S165-74. PubMed ID: 26152417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Adulticidal Efficacy of Imidacloprid 10 %/Moxidectin 2.5 % (w/v) Spot-on (Advocate®, Advantage® Multi) against Dirofilaria repens in Experimentally Infected Dogs.
    Petry G; Genchi M; Schmidt H; Schaper R; Lawrenz B; Genchi C
    Parasitol Res; 2015 Aug; 114 Suppl 1():S131-44. PubMed ID: 26152414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of imidacloprid/moxidectin spot-on solution and fenbendazole in the treatment of dogs naturally infected with Angiostrongylus vasorum (Baillet, 1866).
    Willesen JL; Kristensen AT; Jensen AL; Heine J; Koch J
    Vet Parasitol; 2007 Jul; 147(3-4):258-64. PubMed ID: 17544583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of imidacloprid 10%/moxidectin 1% spot-on formulation in the treatment of feline aelurostrongylosis.
    Traversa D; Di Cesare A; Milillo P; Lohr B; Iorio R; Pampurini F; Schaper R; Paoletti B; Heine J
    Parasitol Res; 2009 Aug; 105 Suppl 1():S55-62. PubMed ID: 19575226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Persistent Preventive Efficacy of 2.5 % Moxidectin/10 % Imidacloprid Spot-on (Advocate®, Advantage® Multi) in Dogs Experimentally Infected with Angiostrongylus vasorum.
    Böhm C; Petry G; Schmidt H; Raue K; Barthel F; Schaper R
    Parasitol Res; 2017 Aug; 116(Suppl 1):1-10. PubMed ID: 28717944
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of imidacloprid 10%/moxidectin 1% spot-on formulation (Advocate®) in the prevention and treatment of feline aelurostrongylosis.
    Heuer L; Petry G; Pollmeier M; Schaper R; Deuster K; Schmidt H; Blazejak K; Strube C; Di Cesare A; Traversa D; Schnyder M; McKay-Demeler J; von Samson-Himmelstjerna G; Mangold-Gehring S; Böhm C
    Parasit Vectors; 2020 Feb; 13(1):65. PubMed ID: 32051008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficacy of imidacloprid 10 % / moxidectin 2.5 % (Advocate®, Advantage® Multi, Bayer) for the prevention of Dirofilaria repens infection in dogs.
    Genchi C; Genchi M; Petry G; Kruedewagen EM; Schaper R
    Parasitol Res; 2013 Aug; 112 Suppl 1():81-9. PubMed ID: 23774842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of parasitological findings in heartworm-infected beagles treated with Advantage Multi® for dogs (10% imidacloprid + 2.5% moxidectin) and doxycycline.
    Savadelis MD; Ohmes CM; Hostetler JA; Settje TL; Zolynas R; Dzimianski MT; Moorhead AR
    Parasit Vectors; 2017 May; 10(1):245. PubMed ID: 28526088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of moxidectin 2.5% and imidacloprid 10% in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected dogs.
    Otranto D; Colella V; Crescenzo G; Solari Basano F; Nazzari R; Capelli G; Petry G; Schaper R; Pollmeier M; Mallia E; Dantas-Torres F; Lia RP
    Vet Parasitol; 2016 Aug; 227():118-21. PubMed ID: 27523947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy and safety of two treatment regimens with a topically applied combination of imidacloprid and moxidectin (Advocate) against generalised demodicosis in dogs.
    Fourie JJ; Delport PC; Fourie LJ; Heine J; Horak IG; Krieger KJ
    Parasitol Res; 2009 Aug; 105 Suppl 1():S115-24. PubMed ID: 19575232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a moxidectin/imidacloprid spot-on formulation (Advocate
    Diakou A; Morelli S; Dimzas D; Di Cesare A; Capelli G; Parrinello C; Pollmeier M; Schaper R; Traversa D
    Parasit Vectors; 2019 Nov; 12(1):519. PubMed ID: 31685011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field study.
    Krieger K; Heine J; Dumont P; Hellmann K
    Parasitol Res; 2005 Oct; 97 Suppl 1():S81-S88. PubMed ID: 16228280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of the safety and efficacy of 10% imidacloprid + 2.5% moxidectin topical solution for the treatment of ear mite (Otodectes cynotis) infestations in dogs.
    Arther RG; Davis WL; Jacobsen JA; Lewis VA; Settje TL
    Vet Parasitol; 2015 May; 210(1-2):64-8. PubMed ID: 25801226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lungworm (Crenosoma vulpis) infection in dogs on Prince Edward Island.
    Bihr T; Conboy GA
    Can Vet J; 1999 Aug; 40(8):555-9. PubMed ID: 12001335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of dog thelaziosis caused by Thelazia callipaeda (Spirurida, Thelaziidae) using a topical formulation of imidacloprid 10% and moxidectin 2.5%.
    Bianciardi P; Otranto D
    Vet Parasitol; 2005 Apr; 129(1-2):89-93. PubMed ID: 15817208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of orally administered fluralaner (Bravecto™) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs.
    Fourie JJ; Liebenberg JE; Horak IG; Taenzler J; Heckeroth AR; Frénais R
    Parasit Vectors; 2015 Mar; 8():187. PubMed ID: 25881320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.